✦ LIBER ✦

Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer

✍ Scribed by Ragaz, Joseph; Jackson, Stewart M.; Le, Nhu; Plenderleith, Ian H.; Spinelli, John J.; Basco, Vivian E.; Wilson, Kenneth S.; Knowling, Margaret A.; Coppin, Christopher M.L.; Paradis, Marilyn; Coldman, Andrew J.; Olivotto, Ivo A.

Book ID: 127181392
Publisher: Massachusetts Medical Society
Year: 1997
Tongue: English
Weight: 95 KB
Volume: 337
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejm199710023371402

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant radiotherapy and chemotherapy i

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer: J Ragaz, SM Jackson, N Le et al N Engl J Med 1997 ; 337: 956–962

✍ Christophe Louvet 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 119 KB

Postoperative Radiotherapy in High-Risk

Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy

✍ Overgaard, Marie; Hansen, Per S.; Overgaard, Jens; Rose, Carsten; Andersson, Mic 📂 Article 📅 1997 🏛 Massachusetts Medical Society 🌐 English ⚖ 149 KB

Adjuvant chemotherapy for operable breas

Adjuvant chemotherapy for operable breast cancer with positive axillary nodes

✍ Stephen K. Carter 📂 Article 📅 1977 🏛 Springer-Verlag 🌐 English ⚖ 420 KB

Cost-utility analysis of adjuvant gosere

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer

✍ Tsui Fen Cheng; Jung Der Wang; Wu Ching Uen 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 308 KB

96137544 Ovarian function in premenopaus

96137544 Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

✍ J. Bines; D.M. Oleske; M.A. Cobleigh 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Adjuvant trastuzumab with chemotherapy i

Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer

✍ Heather L. McArthur; Kathleen M. Mahoney; Patrick G. Morris; Sujata Patil; Linds 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB 👁 1 views

## Abstract ## BACKGROUND: Several large, randomized trials established the benefits of adjuvant trastuzumab with chemotherapy. However, the benefit for women with small, node‐negative HER2‐positive (HER2+) disease is unknown, as these patients were largely excluded from these trials. Therefore, a